Petros Pharmaceuticals Inc (PTPI)
0.6449
0.00 (0.00%)
USD |
NASDAQ |
Apr 26, 15:04
Petros Pharmaceuticals Shareholders Equity (Quarterly): 12.48M for Dec. 31, 2023
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 12.48M |
| September 30, 2023 | 7.057M |
| June 30, 2023 | 12.94M |
| March 31, 2023 | 15.45M |
| December 31, 2022 | 16.70M |
| September 30, 2022 | 20.70M |
| June 30, 2022 | 34.22M |
| Date | Value |
|---|---|
| March 31, 2022 | 35.73M |
| December 31, 2021 | 35.54M |
| September 30, 2021 | 17.85M |
| June 30, 2021 | 19.49M |
| March 31, 2021 | 20.92M |
| December 31, 2020 | 17.47M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
7.057M
Minimum
Sep 2023
35.73M
Maximum
Mar 2022
20.50M
Average
17.85M
Median
Sep 2021
Shareholders Equity (Quarterly) Benchmarks
| Avalo Therapeutics Inc | 7.304M |
| Spectral AI Inc | 1.456M |
| Imunon Inc | 13.39M |
| Assembly Biosciences Inc | 41.10M |
| iBio Inc | 9.197M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 33.80M |
| Total Liabilities (Quarterly) | 21.32M |
| Debt to Equity Ratio | 0.6421 |
| Current Ratio | 1.893 |
| Net Debt Paydown Yield | 7.82% |